Michael H. Davidson - Jan 2, 2025 Form 4 Insider Report for Silence Therapeutics plc (SLN)

Role
Director
Signature
/s/ Rhonda Hellums, Attorney-in-Fact
Stock symbol
SLN
Transactions as of
Jan 2, 2025
Transactions value $
$0
Form type
4
Date filed
1/6/2025, 04:15 PM
Previous filing
Dec 12, 2024
Next filing
Jan 7, 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLN Share Option (Right to Buy) Award $0 +48K $0.00 48K Jan 2, 2025 Ordinary Shares 48K $2.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in equal monthly installments over a three-year period measured from one month following January 2, 2025, subject to the Reporting Person's continuous service as of each applicable vesting date.